Open Access

How potassium binders can enable RAASi therapy in heart failure.


Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)
Organised by PACE-CME - Supported by an unrestricted educational grant from AstraZeneca

Congress Presentation

About the speaker

Doctor Mikhail Kosiborod

St. Luke's Mid America Heart Institute, Kansas City (United States of America)
44 presentations

4 more presentations in this session

Clinical case presentation of a patient with heart failure.

Speaker: Professor P. Van Der Meer (Groningen, NL)


The importance of optimal RAASi therapy in heart failure.

Speaker: Professor D. Atar (Oslo, NO)


Practical guidance on use of potassium binders in the management of hyperkalemia in heart failure.

Speaker: Doctor C. Bonanad Lozano (Valencia, ES)


Panel discussion.

Speaker: Professor P. Van Der Meer (Groningen, NL)


Access the full session

Clinical case discussion: the value of optimising RAAS inhibition and preserving normokalemia in heart failure

Speakers: Doctor M. Kosiborod, Professor P. Van Der Meer, Professor D. Atar, Doctor C. Bonanad Lozano, Professor P. Van Der Meer

About the event


ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb